Mice Model Market

By Type;

Inbred Mice, Outbred Mice, Genetically Engineered Mice, Hybrid/Congenic Mice, Conditioned/Surgically Modified Mice, and Spontaneous Mutant Mice

By Services;

Breeding and Rederivation

By Application;

Research and Drug Discovery

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn738798119 Published Date: June, 2025 Updated Date: August, 2025

Mice Model Market Overview

Mice Model Market (USD Million)

Mice Model Market was valued at USD 1,735.45 million in the year 2024. The size of this market is expected to increase to USD 2,828.96 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.2%.


Mice Model Market

*Market size in USD million

CAGR 7.2 %


Study Period2025 - 2031
Base Year2024
CAGR (%)7.2 %
Market Size (2024)USD 1,735.45 Million
Market Size (2031)USD 2,828.96 Million
Market ConcentrationMedium
Report Pages381
1,735.45
2024
2,828.96
2031

Major Players

  • Charles River Laboratories International, Inc.
  • The Jackson Laboratory
  • Taconic Biosciences, Inc.
  • ENVIGO
  • Laboratory Corporation of America Holdings
  • Janvier Labs
  • Harbour Antibodies Bv (A Subsidiary of Harbour Biomed)
  • Trans Genic, Inc.
  • Genoway
  • Horizon Discovery Group PLC (Sage Labs, Inc.)
  • Ingenious Targeting Laboratory

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Mice Model Market

Fragmented - Highly competitive market without dominant players


The Mice Model Market is experiencing substantial growth due to the increasing reliance on animal models for drug discovery and disease research. Mice models account for over 60% of preclinical testing efforts, driven by their genetic similarity to humans and ease of genetic manipulation. The trend is being amplified by rising investments in biomedical R&D and the development of novel therapeutic areas including oncology and neurology.

Genetic Engineering Advancements
Recent progress in gene-editing technologies like CRISPR has boosted the demand for genetically modified mice, enabling precise disease modeling. This has led to a 35% rise in customized mouse model usage, significantly improving the predictability of treatment outcomes. The increasing sophistication of transgenic and knockout models continues to fuel research adoption rates in academic and pharmaceutical settings.

Application in Personalized Medicine
The growing emphasis on personalized medicine has expanded the role of humanized mice, with adoption growing by over 40% in the past few years. These models are pivotal in replicating patient-specific responses, especially in immunotherapy and rare disease studies. The accuracy and relevance of these models are transforming early-stage validation of treatment approaches.

Regulatory and Ethical Considerations
Despite their advantages, the market faces scrutiny over ethical concerns and evolving regulations, which have prompted a 20% increase in demand for alternatives like in vitro methods. However, mice models remain indispensable due to their proven reliability in mimicking human disease biology, especially in long-term efficacy and toxicity studies.

Technological Integration and Future Outlook
Integration of AI and digital imaging tools in model evaluation is accelerating research timelines and enhancing reproducibility. These innovations have led to a 25% improvement in efficiency and data accuracy, paving the way for a more refined use of mice models. As precision research and AI-driven analytics converge, the market is expected to sustain robust momentum in the coming years.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Services
    3. Market Snapshot, By Application
    4. Market Snapshot, By Region
  4. Mice Model Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing biomedical research demand
        2. Technological advancements enhancing precision
        3. Growing prevalence of chronic diseases
        4. Rising focus on personalized medicine
        5. Expanded application in drug development
      2. Restraints
        1. Ethical concerns and regulations
        2. High costs of maintenance
        3. Complexities in genetic manipulation
        4. Limited availability of skilled professionals
        5. Variability in experimental outcomes
      3. Opportunities
        1. Emerging economies' adoption
        2. Development of novel disease models
        3. Collaborative research initiatives
        4. Advancements in CRISPR technology
        5. Expansion of preclinical studies
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Mice Model Market, By Type, 2021 - 2031 (USD Million)
      1. Inbred Mice
      2. Outbred Mice
      3. Genetically Engineered Mice
      4. Hybrid/Congenic Mice
      5. Conditioned/Surgically Modified Mice
      6. Spontaneous Mutant Mice
      7. Mice Model Market, By Services, 2021 - 2031 (USD Million)
        1. Breeding
        2. Rederivation
      8. Mice Model Market, By Application, 2021 - 2031 (USD Million)
        1. Research
        2. Drug Discovery
      9. Mice Model Market, By Geography, 2021 - 2031 (USD Million)
        1. North America
          1. United States
          2. Canada
        2. Europe
          1. Germany
          2. United Kingdom
          3. France
          4. Italy
          5. Spain
          6. Nordic
          7. Benelux
          8. Rest of Europe
        3. Asia Pacific
          1. Japan
          2. China
          3. India
          4. Australia & New Zealand
          5. South Korea
          6. ASEAN (Association of South East Asian Countries)
          7. Rest of Asia Pacific
        4. Middle East & Africa
          1. GCC
          2. Israel
          3. South Africa
          4. Rest of Middle East & Africa
        5. Latin America
          1. Brazil
          2. Mexico
          3. Argentina
          4. Rest of Latin America
    2. Competitive Landscape
      1. Company Profiles
        1. Charles River Laboratories International, Inc.
        2. The Jackson Laboratory
        3. Taconic Biosciences, Inc.
        4. ENVIGO
        5. Laboratory Corporation of America Holdings
        6. Janvier Labs
        7. Harbour Antibodies Bv (A Subsidiary of Harbour Biomed)
        8. Trans Genic, Inc.
        9. Genoway
        10. Horizon Discovery Group PLC (Sage Labs, Inc.)
        11. Ingenious Targeting Laboratory
    3. Analyst Views
    4. Future Outlook of the Market